insights_auto
Pse është rritur TWST 5,91%?
Zhytu më thellëchevron_right
TWST:NASDAQ
Twist Bioscience Corp
148,03 US$
arrow_upward
+5,91%(+8,26) 1D
20 tet, 12:39:08 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për TWST...
Hap
139,77 US$
I lartë
148,83 US$
I ulët
134,94 US$
Kapitalizimi i tregut
9,81 mld
Vëllimi mesatar
2,84 mln
Vëllimi
1,01 mln
Maksimumi 52-javor
219,71 US$
Minimumi 52-javor
23,30 US$
Fitimet për aksion
-2,22 US$
Beta
2,19
Aksionet në qarkullim
65,83 mln
Numri i punonjësve
979
Hap
139,77 US$
I lartë
148,83 US$
I ulët
134,94 US$
Kapitalizimi i tregut
9,81 mld
Vëllimi mesatar
2,84 mln
Vëllimi
1,01 mln
Maksimumi 52-javor
219,71 US$
Minimumi 52-javor
23,30 US$
Fitimet për aksion
-2,22 US$
Beta
2,19
Aksionet në qarkullim
65,83 mln
Numri i punonjësve
979
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
ad-hoc-news.de
·
4 orë më parë
TD Cowen lifts target to USD 190 for Twist Bioscience stock
Simply Wall Street
·
8 orë më parë
Is Twist Bioscience (TWST) Too Rich Or Still Reasonable On Sales?
Profili
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Rreth Twist Bioscience Corp
Drejtori ekzekutivEmily Leproust
Punonjësit979
Themeluar më2013
Selia-
Sektori-
Uebsajtitwistbioscience.com